These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 3100424)

  • 21. Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.
    Tomioka H; Sato K; Saito H
    Tubercle; 1991 Sep; 72(3):176-80. PubMed ID: 1771676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
    Tsukamura M
    Microbiol Immunol; 1987; 31(7):615-23. PubMed ID: 3125413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.
    Casal M; Gutierrez J; González J; Ruiz P
    Chemioterapia; 1987 Dec; 6(6):437-9. PubMed ID: 3124964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.
    Fenlon CH; Cynamon MH
    Antimicrob Agents Chemother; 1986 Mar; 29(3):386-8. PubMed ID: 2940969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
    Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique.
    Luo X; Pires D; Aínsa JA; Gracia B; Mulhovo S; Duarte A; Anes E; Ferreira MJ
    J Ethnopharmacol; 2011 Sep; 137(1):114-20. PubMed ID: 21571059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
    Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA
    Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472
    [No Abstract]   [Full Text] [Related]  

  • 30. New antimycobacterial S-alkylisothiosemicarbazones.
    Waisser K; Heinisch L; Slosárek M; Janota J
    Folia Microbiol (Praha); 2005; 50(6):479-81. PubMed ID: 16681143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of five new quinolones against cultivable mycobacteria.
    Pattyn SR; Van Caekenberghe DL; Verhoeven JR
    Eur J Clin Microbiol; 1987 Oct; 6(5):572-3. PubMed ID: 3125049
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.
    Steadham JE; Stall SK; Simmank JL
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antimycobacterial activities of minocycline and ciprofloxacin].
    Arai T; Komatsu S; Aoyagi T
    Kekkaku; 1985 May; 60(5):293-7. PubMed ID: 3162057
    [No Abstract]   [Full Text] [Related]  

  • 34. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
    Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro activity of ciprofloxacin against clinical isolates of mycobacteria resistant to antimycobacterial drugs.
    Marinis E; Legakis NJ
    J Antimicrob Chemother; 1985 Oct; 16(4):527-30. PubMed ID: 2933382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of the effects of chlorhexidine diacetate and cetylpyridinium chloride on mycobacteria by ethambutol.
    Broadley SJ; Jenkins PA; Furr JR; Russell AD
    J Med Microbiol; 1995 Dec; 43(6):458-60. PubMed ID: 7473681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimycobacterial activity of natural and semi-synthetic lignans.
    Silva ML; Martins CH; Lucarini R; Sato DN; Pavanb FR; Freitas NH; Andrade LN; Pereira AC; Bianco TN; Vinholis AH; Cunha WR; Bastos JK; Silva R; Da Silva Filho AA
    Z Naturforsch C J Biosci; 2009; 64(11-12):779-84. PubMed ID: 20158145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic effect of ofloxacin on mice challenged by ofloxacin-resistant Mycobacterium bovis strains].
    Tsukamura M
    Kekkaku; 1987 Apr; 62(4):235-8. PubMed ID: 3306084
    [No Abstract]   [Full Text] [Related]  

  • 39. Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks?
    Malík I; Csöllei J; Solovič I; Pospíšilová Š; Michnová H; Jampílek J; Čížek A; Kapustíková I; Čurillová J; Pecháčová M; Stolaříková J; Pecher D; Oravec M
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30274224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
    Casal M; Rodríguez F; Gutierrez J; Ruiz P; Benavente MC; Villalba R; Moreno G
    J Chemother; 1989 Feb; 1(1):39-45. PubMed ID: 2498468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.